AbCellera Biologics Inc (NAS:ABCL)
$ 2.995 0.045 (1.53%) Market Cap: 871.33 Mil Enterprise Value: 299.59 Mil PE Ratio: 0 PB Ratio: 0.81 GF Score: 66/100

Abcellera Biologics Inc at Bloom Burton & Co. Healthcare Investor Conference Transcript

May 02, 2022 / 01:30PM GMT
Release Date Price: $8.07 (+5.22%)
Vincent Nadeau
Bloom Burton & Co. - Analyst

Welcome to the 2022 Bloom Burton Healthcare Investment Conference this morning. You are in Hall C and D, which is a large hall. This morning, we have a series of sessions, series of presentations with biotech companies. We will have also a fireside chat midway through with BELLUS Health. But to start, we have Carl Hansen here, Chairman, CEO and President of AbCellera Biologics. Carl, take it away.

Carl Hansen
AbCellera Biologics Inc. - Chairman, CEO & President

All right, thank you so much. Can everyone hear me? Great. So first, let me say what a pleasure it is to finally be back in three dimensions after three years. We had a terrific dinner last night and conversation, got to meet many of the people that I've only met through Zoom, and also to reconnect with some old friends. I really think that Canada has a remarkable community in terms of the support and people cheering for each other across the country. And it's really heartwarming to be back, back in that event, and so I wanted to thank the team of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot